Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

Hannover Medical School1 enrolled

Overview

Clinical use of ex-vivo perfusion for lung transplantation. Collection, storage and processing of patient data for outcome analysis.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Lung Transplantation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Min Age 18 years * Acceptance of the organ using the XPS™ ex vivo lung perfusion system is made by the center based on clinical assessment and visual inspection Exclusion Criteria: * The usual criteria for the assessment of donors apply * The transplanting surgeon is not satisfied with the lung assessment on the XPS™ according to clinical criteria

Locations (1)

Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular Surgery

Hanover, Germany

Outcomes

Primary Outcomes

Survival of patients 1 year after transplantation

Time frame: 1 year after transplantation

Secondary Outcomes

Occurrence of primary graft dysfunction (PGD) after transplantation

Time frame: 0, 24, 48, 72 hours postTx

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.